Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02373358 · ClinicalTrials.gov registry record · NA

Evaluation of Effectiveness of a Group Yoga Intervention as Trauma Therapy for Adolescent Girls

A NA study of PTSD, sponsored by Hamilton Health Sciences Corporation.

Completed
Registry status
NA
Development phase
34
Enrollment target
2
Study locations

NCT02373358: Completed NA study of PTSD, sponsored by Hamilton Health Sciences Corporation.

NCT02373358 is a NA study of PTSD that has completed, run by Hamilton Health Sciences Corporation. The registered enrollment target is 34 participants, below the 302-participant average among 154 other PTSD trials with a reported enrollment target (89% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02373358, a NA study of PTSD, has completed, sponsored by Hamilton Health Sciences Corporation.

COMPLETED
Registry status
NA
Development phase
34 participants
Enrollment target
2
Study locations

Study Summary

Neuroscience evidence indicates that trauma is stored in the body, that trauma impairs the language centers found in the brain, and that emotion centers in the brain tend to override cognitive centers in the brain following trauma. Most evidence-based models to date to treat trauma using cognitive therapy, which does not fully resolve symptoms, particularly in the case of complex trauma. This evidence has led to researchers to call for alternative, body-oriented treatments that target trauma from the lowest levels of regulation up to higher levels of regulation in the brain. Yoga has been proposed as one such intervention. Recent research has investigated the benefits of yoga to treatment adult females who have experienced PTSD, but only anecdotal, descriptive, and qualitative data is available for studies of yoga with adolescents. This mixed methods study seeks to generate quantitative data demonstrating whether or not the 6-week group yoga intervention leads to decreases in general mental health and trauma-specific symptoms and qualitative data regarding the components of the intervention the participants found both helpful and unhelpful.

Primary Outcome

The Youth Outcomes Questionnaire-Self Report (YOQ-SR) is used to evaluate treatment outcomes based on global symptom reduction (Wells, Burlingame, \& Lambert, 2003). The YOQ is very sensitive to change, and individuals are asked to report on their symptoms within the last seven days. The 64-item questionnaire produces a total score of -16 to 240 (due to negative scores being awarded for reverse-scored items, a negative score is possible). Symptoms are rated on a 5-point Likert scale from Never o

Conditions Studied

Interventions

  • BEHAVIORAL Group yoga intervention

Study Locations (2)

Colorado

  • Denver Children's Advocacy Center - Denver

Ontario

  • Hamilton Health Sciences - Hamilton

Trial Details

FieldValue
Enrollment Target 34 participants
Start Date 2015-05
Est. Completion 2015-09
Phase NA

What the finished NCT02373358 record still lists

NCT02373358 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 302-participant average among 154 other PTSD trials with a reported enrollment target (89% lower).

The record links to 1 condition, with PTSD appearing as the primary indexed condition, and to 1 intervention - of which Group yoga intervention is the first listed.

NCT02373358 reports a single indexed study location in Colorado, Ontario.

Frequently Asked Questions

What is clinical trial NCT02373358 about?

NCT02373358 is a clinical study titled "Evaluation of Effectiveness of a Group Yoga Intervention as Trauma Therapy for Adolescent Girls". Neuroscience evidence indicates that trauma is stored in the body, that trauma impairs the language centers found in the brain, and that emotion centers in the brain tend to override cognitive centers in the brain following trauma. Most evidence-based models to date to treat trauma using cognitive t...

What is the current status of trial NCT02373358?

This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2015-05. Estimated completion is 2015-09.

What conditions does trial NCT02373358 study?

This clinical trial studies the following conditions: PTSD.

What interventions are being tested in trial NCT02373358?

The interventions under investigation include: Group yoga intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT02373358?

This trial is sponsored by Hamilton Health Sciences Corporation, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02373358 being conducted?

This trial has 2 study locations across Colorado, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for PTSD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02373358's enrollment target sits among peer trials

34 119th of 154 higher than 36 of 154 other PTSD trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other PTSD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02897063 · 34 participants · Phase 1

    Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure

  • NCT03906617 · 34 participants · Phase 4

    Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine

  • NCT03992378 · 34 participants · NA

    Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis

  • NCT04047849 · 34 participants · Phase 4

    Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02373358, the US trial registry maintained by the National Library of Medicine. NCT02373358 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.